# Vester Brief
> One original governance investigation every week: how boards, CEOs, and controlling owners really decide. By Steffen Brenner, Copenhagen Business School.
Public Ghost content for AI and LLM tooling. Use `/llms-full.txt` for consolidated page and post context.
Append `.md` to any post or page URL to get the content in Markdown (for example, `/example-post.md`).

## Pages
- [About](https://www.vesterbrief.com/about.md) - Corporate governance is full of accepted wisdom. Independent directors improve oversight. Bonuses motivate executives. Foundations create stability. More disclosure leads to better decisions. Sometimes these ideas are right. Sometimes they aren't. The Vester Brief investigates one governance puzzle…
- [An Offer No Director Can Decline: Board data, methods and sources](https://www.vesterbrief.com/an-offer-no-director-can-decline-board-data-methods-and-sources.md) - The full board table, network methodology and sources behind 'An Offer No Director Can Decline.'
- [Business Ethics](https://www.vesterbrief.com/business-ethics.md) - DIP-DIBUO2404U Ethics in International Business LECTURES About Feedback Read the lecture material → Work the micro-case → Ask the Companion → Review last lecture → Last lecture's summary is being prepared. The material for this lecture isn't published yet. There is no micro-case for this lecture. ←…
- [LEGO](https://www.vesterbrief.com/lego.md) - KAN-CPOLV2502U Leadership and Governance at Multinational Enterprises LECTURES About Feedback Work the micro-case → Read the lecture material → Ask the Companion → Join today's poll → Review last lecture → Last lecture's summary is being prepared. The material for this lecture isn't published yet.…
- [The Billion-Dollar Signature; Data, Methods, and Sources](https://www.vesterbrief.com/the-billion-dollar-signature-data-methods-and-sources.md) - Sources: the June 2025 option grant, its forfeiture conditions, the abandonment of the separation and the committee's stated reasoning per WBD's annual proxy filed 30 April 2026 (accession 0001437107-26-000046). The January 2026 grants per the FY2025 Form 10-K. The tax reimbursement agreement of 10…

## Posts
- [The Billion-Dollar Signature](https://www.vesterbrief.com/the-billion-dollar-signature.md) - Paying Warner Bros. Discovery's chief executive for signing a deal rather than completing one is a remarkable board decision. Chief executives in the media industry are well paid. Warner Bros. Discovery's board was willing to go beyond that and pay on top of it. Initially it wanted a corporate rest…
- [An Offer No Director Can Decline](https://www.vesterbrief.com/an-offer-no-director-can-decline.md) - The Sale of CNN and the Political Limits of Board Independence Warner Bros. Discovery spent the past year as the most sought-after target in media. Netflix wanted the studios and the streaming platform. Paramount wanted everything, including CNN. Between December and February, the board had to deci…
- [Bonus, in Danish](https://www.vesterbrief.com/bonus-in-danish.md) - CEOs are often rewarded for being in the right industry at the right time. When oil prices rise, oil CEOs become geniuses. When interest rates rise, bank CEOs suddenly do too. Bertrand and Mullainathan (2001) gave this a name: "pay for luck." They identified it as a central governance failure. The…
- [Wall Street's Half-Finished Revolution](https://www.vesterbrief.com/wall-streets-half-finished-revolution.md) - Wall Street transformed opportunities for women. Five years after its first female CEO, how much should you bet on another? We analyzed 2,167 careers to find out. In late June, Marianne Lake left JPMorgan after twenty-five years: CEO of its consumer bank, and the last woman in the race to succeed J…
- [Novo vs. Lilly: Do Mega-Caps Need Strong Leaders—or Strong Governance?](https://www.vesterbrief.com/novo-vs-lilly-can-mega-caps-have-owners-without-owners.md) - Dave Ricks proves it quarterly. Lars Rebien Sørensen proved it a decade ago. Which mandate wins? One of Europe's Greatest Corporate Success Stories Novo Nordisk transformed diabetes care. Ozempic and Wegovy turned obesity into one of the fastest-growing pharmaceutical markets in history. By 2024, N…

## Optional
- [RSS Feed](https://www.vesterbrief.com/rss/)
- [Sitemap](https://www.vesterbrief.com/sitemap.xml)
- [Full content of pages and posts](https://www.vesterbrief.com/llms-full.txt)